Madrigal Pharmaceuticals Inc (MDGL)
US$ 303.705-10.39%
Price Chart
Key Statistics
Market Cap
$ 6.71B
P/E Ratio
0.00
Revenue (TTM)
$ 317.38M
Volume
1M
52W High
$ 377.46
52W Low
$ 200.63
Dividend Yield
0.00%
Beta
-1.06
Technicals
50-Day MA
294.62
200-Day MA
306.9661
52 Week High
377.46
52 Week Low
200.63
About MDGL
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States.
Employees
528
Headquarters
West Conshohocken, PA
CEO
Mr. William J. Sibold
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg